Nektar Therapeutics reported $83.99M in Current Liabilities for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Agios Pharmaceuticals AGIO:US USD 53.6M 5.2M
ALKERMES ALKS:US USD 469.56M 31.04M
Amgen AMGN:US USD 14.33B 1.71B
Astrazeneca AZN:US USD 24.85B 3.04B
Baxter International BAX:US USD 3.71B 208M
Biogen BIIB:US USD 3.93B 1.09B
Bluebird Bio BLUE:US USD 126.73M 22.13M
Bristol Myers Squibb BMY:US USD 18.93B 1.98B
Cara Therapeutics CARA:US USD 28.19M 7.02M
Eisai 4523:JP JPY 266.54B 35.36B
Eli Lilly And LLY:US USD 15.65B 32.2M
Esperion Therapeutics ESPR:US USD 82.34M 70K
Exelixis EXEL:US USD 301.73M 2.79M
Gilead Sciences GILD:US USD 10.42B 1.2B
GlaxoSmithKline GSK:LN GBP 20.95B 16.88B
Halozyme Therapeutics HALO:US USD 109.38M 90.13M
Immunogen IMGN:US USD 103.64M 16.57M
IONIS PHARMACEUT IONS:US USD 283.45M 15.64M
Ironwood Pharmaceuticals IRWD:US USD 27.12M 3.82M
Karyopharm Therapeutics KPTI:US USD 61.76M 780K
Macrogenics MGNX:US USD 50.05M 831K
Mirati Therapeutics MRTX:US USD 126.99M 7.84M
Nektar Therapeutics NKTR:US USD 83.99M 21M
Neurocrine Biosciences NBIX:US USD 485.1M 199.4M
Novartis NOVN:VX USD 28.16B 514M
Roche Holding ROG:VX 27.41B 11.01B
Sarepta Therapeutics SRPT:US USD 602.92M 57.35M
Seattle Genetics SGEN:US USD 726M 117.48M
Takeda 4502:JP JPY 2.39T 224.78B
Teva Pharmaceutical TEVA:IT USD 11.53B 538M
Xencor XNCR:US USD 90.03M 14.99M
YTE INCY:US USD 1.01B 79.92M